Investing
Abercrombie, OvaScience Slide Into Thursday's 52-Week Low Club
Published:
Last Updated:
December 22, 2016: Here are four stocks trading with relatively heavy volume among 67 equities making new 52-week lows in Thursday’s session. On the NYSE, decliners led advancers by about 3 to 2 and on the Nasdaq decliners led advancers by about 9 to 5.
OvaScience Inc. (NASDAQ: OVAS) dropped about 56% on Thursday to post a new 52-week low of $1.32 against a 52-week high of $11.66 and a Wednesday close of $2.97. Volume of about 9.4 million was nearly 10 times the daily average of around 530,000. The fertility biotech firm laid off a third of its workforce and the CEO resigned after just six months on the job.
Abercrombie & Fitch Inc. (NYSE: ANF) dropped about 6.4% on Thursday to post a new 52-week low of $12.02 after closing at $12.84 on Wednesday. The stock’s 52-week high is $32.93. Volume of about 3.8 million shares totaled roughly 15% more than the daily average of about 3.4 million. The specialty retailer had no specific news.
Amicus Therapeutics Inc. (NASDAQ: FOLD) dropped about 6.2% on Thursday to post a new 52-week low of $4.41 after closing at $4.67 on Wednesday. The stock’s 52-week high is $9.99. Volume was about 25% above the daily average of around 3.5 million shares. The company had no specific news Thursday.
Primero Mining Co. (NYSE: PPP) dropped about 1.4% Thursday to post a new 52-week low of $0.70after closing Wednesday at $0.71. The 52-week high is $2.73. Volume of around 2.8 million was about 40% more than the daily average of around 1.8 million shares traded. The company had no specific news.
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.